4//SEC Filing
GOLDSMITH MARK A 4
Accession 0001610717-25-000375
CIK 0001628171other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 8:12 PM ET
Size
20.7 KB
Accession
0001610717-25-000375
Insider Transaction Report
Form 4
GOLDSMITH MARK A
DirectorSee Remarks
Transactions
- Sale
Common Stock
2025-11-07$60.31/sh−30,000$1,809,306→ 347,863 total - Gift
Common Stock
2025-11-12−50,000→ 297,863 total - Gift
Common Stock
2025-11-12+50,000→ 70,424 total(indirect: By Trust) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-07−3,521→ 177,708 totalExercise: $4.09From: 2023-03-13Exp: 2029-03-12→ Common Stock (3,521 underlying) - Exercise/Conversion
Common Stock
2025-11-07$4.09/sh+3,521$14,401→ 377,863 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-07−26,479→ 0 totalExercise: $1.12From: 2022-03-29Exp: 2028-04-19→ Common Stock (26,479 underlying) - Exercise/Conversion
Common Stock
2025-11-07$1.12/sh+26,479$29,656→ 374,342 total - Gift
Common Stock
2025-11-12−50,000→ 247,863 total - Gift
Common Stock
2025-11-12+50,000→ 54,498 total(indirect: By Trust)
Holdings
- 15,926(indirect: By Trust)
Common Stock
- 570,050(indirect: By Trust)
Common Stock
Footnotes (11)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.
- [F10]Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
- [F11]Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
- [F2]Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust.
- [F3]Includes 193,475 restricted stock units.
- [F4]This transaction was executed in multiple trades at prices ranging from $60.00 to $60.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]Represents a transfer to the Jonathan Goldsmith Revocable Trust.
- [F6]Represents a transfer to the Rebecca Goldsmith Revocable Trust.
- [F7]Held by Jonathan Goldsmith Revocable Trust.
- [F8]Reflects the transfer of 4,498 shares.
- [F9]Held by Rebecca Goldsmith Revocable Trust.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001246842
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 8:12 PM ET
- Size
- 20.7 KB